Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 37Terminated 12Recruiting 12Active not recruiting 6Unknown 4Withdrawn 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 1

Conditions

Head and Neck Neoplasms 101Squamous Cell Carcinoma of Head and Neck 76Oropharyngeal Neoplasms 19Carcinoma, Squamous Cell 16Thyroid Neoplasms 15Carcinoma, Non-Small-Cell Lung 12Breast Neoplasms 11Carcinoma 10Neoplasms 9Mouth Neoplasms 9Lung Neoplasms 9Laryngeal Neoplasms 9Tongue Neoplasms 8Stomach Neoplasms 7Salivary Gland Neoplasms 7Neoplasm Metastasis 7Prostatic Neoplasms 6Ovarian Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Thyroid Carcinoma, Anaplastic 5Small Cell Lung Carcinoma 5Melanoma 5Esophageal Neoplasms 5Pancreatic Neoplasms 4Mucositis 4Carcinoma, Renal Cell 4Xerostomia 3

Interventions

Sugars 1Cetuximab 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Laryngeal Diseases × Head & Neck × Clear all
NCT03214835 2020-07-20

CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

CDx Diagnostics

Phase NA Withdrawn
GastrointestinalHead & Neck

Gastroesophageal Reflux, Laryngeal Diseases, Neoplasms, Laryngopharyngeal Reflux

NCT01427205 2013-04-05

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡